| Standard diagnostics |  |  | Intensified diagnostics |  | OR (CI) | p | |
---|---|---|---|---|---|---|---|---|
Correct care at 8 weeks (for living participants in follow up; n = 47) | ||||||||
 | n for group | n correct care | % correct care | n for group | n correct care | % correct care |  |  |
All participants | 25 | 22 | (88) | 22 | 22 | (100) | Undefined | 0.14 |
TB+ | 9 | 9 | (100) | 9 | 9 | (100) | 1 | Â |
TB- | 16 | 13 | (81) | 13 | 13 | (100) | Undefined | 0.15 |
Smear negative participants | 20 | 17 | (85) | 19 | 19 | (100) | Undefined | 0.12 |
TB+ | 4 | 4 | (100) | 6 | 6 | (100) | 1 | Â |
TB- | 16 | 13 | (81) | 13 | 13 | (100) | Undefined | 0.15 |
Correct care censored at death or last study visit; n = 70 |  |  |  |  |  | |||
 | n for group | n correct care | % correct care | n for group | n correct care | % correct care |  |  |
All participants | 37 | 26 | (70) | 33 | 29 | (88) | 3.1 (0.87,10.8) | 0.06 |
TB+ | 16 | 9 | (56) | 16 | 11 | (69) | 2.1 (0.47, 9.7) | 0.27 |
TB- | 21 | 17 | (81) | 18 | 18 | (100) | Undefined | 0.07 |
Smear negative participants | 32 | 21 | (66) | 27 | 24 | (89) | 4.2 (1.0,17.1) | 0.04 |
TB+ | 11 | 4 | (36) | 9 | 6 | (67) | 3.5 (0.55, 22.3) | 0.18 |
TB- | 21 | 17 | (81) | 18 | 18 | (100) | Undefined | 0.07 |